317 related articles for article (PubMed ID: 33827580)
1. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.
Yang YSH; Ko PJ; Pan YS; Lin HY; Whang-Peng J; Davis PJ; Wang K
J Biomed Sci; 2021 Apr; 28(1):24. PubMed ID: 33827580
[TBL] [Abstract][Full Text] [Related]
2. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
[TBL] [Abstract][Full Text] [Related]
3. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
5. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different
Chin YT; He ZR; Chen CL; Chu HC; Ho Y; Su PY; Yang YSH; Wang K; Shih YJ; Chen YR; Pedersen JZ; Incerpi S; Nana AW; Tang HY; Lin HY; Mousa SA; Davis PJ; Whang-Peng J
Front Endocrinol (Lausanne); 2019; 10():130. PubMed ID: 30915033
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.
Incerpi S; Hsieh MT; Lin HY; Cheng GY; De Vito P; Fiore AM; Ahmed RG; Salvia R; Candelotti E; Leone S; Luly P; Pedersen JZ; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2014 Jul; 307(2):C150-61. PubMed ID: 24808494
[TBL] [Abstract][Full Text] [Related]
7. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
8. Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.
Davis PJ; Mousa SA; Cody V; Tang HY; Lin HY
Horm Cancer; 2013 Dec; 4(6):335-42. PubMed ID: 23943159
[TBL] [Abstract][Full Text] [Related]
9. Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy.
Cheng TM; Chang WJ; Chu HY; De Luca R; Pedersen JZ; Incerpi S; Li ZL; Shih YJ; Lin HY; Wang K; Whang-Peng J
Cells; 2021 Jul; 10(7):. PubMed ID: 34359854
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
[TBL] [Abstract][Full Text] [Related]
11. Actions of Thyroid Hormones on Thyroid Cancers.
Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
Lin HY; Mousa SA; Davis PJ
Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
[TBL] [Abstract][Full Text] [Related]
14. Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells.
Unson S; Chang TC; Yang YN; Wang SH; Huang CH; Crawford DR; Huang HM; Li ZL; Lin HY; Whang-Peng J; Wang K; Davis PJ; Li WS
Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005485
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
16. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
17. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
18. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
19. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis.
Liu YC; Yeh CT; Lin KH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600974
[TBL] [Abstract][Full Text] [Related]
20. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
